AU2782592A - Thermal enhancement of transdermal drug administration - Google Patents

Thermal enhancement of transdermal drug administration

Info

Publication number
AU2782592A
AU2782592A AU27825/92A AU2782592A AU2782592A AU 2782592 A AU2782592 A AU 2782592A AU 27825/92 A AU27825/92 A AU 27825/92A AU 2782592 A AU2782592 A AU 2782592A AU 2782592 A AU2782592 A AU 2782592A
Authority
AU
Australia
Prior art keywords
drug administration
transdermal drug
thermal enhancement
enhancement
thermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27825/92A
Other languages
English (en)
Inventor
Renee A Fallon
Donald R. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cygnus Therapeutic Systems
Original Assignee
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnus Therapeutic Systems filed Critical Cygnus Therapeutic Systems
Publication of AU2782592A publication Critical patent/AU2782592A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
AU27825/92A 1991-10-15 1992-10-07 Thermal enhancement of transdermal drug administration Abandoned AU2782592A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77498991A 1991-10-15 1991-10-15
US774989 1996-12-27

Publications (1)

Publication Number Publication Date
AU2782592A true AU2782592A (en) 1993-05-21

Family

ID=25102961

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27825/92A Abandoned AU2782592A (en) 1991-10-15 1992-10-07 Thermal enhancement of transdermal drug administration

Country Status (3)

Country Link
AU (1) AU2782592A (fr)
PT (1) PT100967A (fr)
WO (1) WO1993007842A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028854A1 (fr) * 1993-06-11 1994-12-22 Koeltringer Peter Procede et dispositif permettant de traiter des tissus du corps
US6756053B2 (en) * 1995-07-28 2004-06-29 Zars, Inc. Controlled heat induced rapid delivery of pharmaceuticals from skin depot
US6284266B1 (en) * 1995-07-28 2001-09-04 Zars, Inc. Methods and apparatus for improved administration of fentanyl and sufentanil
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
JP2002525172A (ja) * 1998-09-29 2002-08-13 ザース・インコーポレーテッド 薬剤活性化合物の改良された適用方法及び装置
DE10234673B4 (de) 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US8211462B2 (en) 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
US8246980B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
KR20060004399A (ko) * 2004-07-09 2006-01-12 에스케이케미칼주식회사 자기발열체를 이용한 케토프로펜의 경피투여 시스템
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
MX2011011698A (es) 2009-05-04 2012-02-29 Zars Pharma Inc Metodo para tratar dolores asociados con neuroma, entrapamiento nervioso y otras condiciones.
ES2847936T3 (es) 2013-10-07 2021-08-04 Teikoku Pharma Usa Inc Métodos y composiciones para el suministro transdérmico de una cantidad no sedante de dexmedetomidina
KR101831290B1 (ko) * 2013-10-07 2018-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물
TWI704933B (zh) * 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879119A (en) * 1984-02-21 1989-11-07 Yamanouchi Pharmaceutical Co., Ltd. Patch
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally

Also Published As

Publication number Publication date
WO1993007842A1 (fr) 1993-04-29
PT100967A (pt) 1994-06-30

Similar Documents

Publication Publication Date Title
ZA928011B (en) Transdermal administration of melatonin.
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
AU609390B2 (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
AU4227793A (en) Drug infuser
EP0800364A4 (fr) Administration percutanee d'apomorphine
AU2782592A (en) Thermal enhancement of transdermal drug administration
AU7070596A (en) Transdermal administration of olanzapine
AU7236596A (en) Transdermal administration of ropinirole and analogs thereof
AU3807795A (en) Medicinal and/or nutritional microcapsules for per os administration
AU1913792A (en) Novel derivatives of thiopyranopyrrole and preparation thereof
GB2255503B (en) Improved use of ß2-bronchodilator drugs
NZ236985A (en) 3-carboxy and thiocarboxy-4-isoxazolecarboxamide ester derivatives; preparation and pharmaceutical preparation
AU6934691A (en) Transdermal administration of zwitterionic drugs
PL314637A1 (en) Adjuvant drug with derivatives of paklitaxel
GB2256588B8 (en) Preparation for transdermal administration of procaterol
AU6807994A (en) Medicinal use of pyridine derivative
AU1846488A (en) Analgesic and anti-inflammatory thiourea derivatives
AU1432292A (en) Drug delivery composition and method of using the same
AU2617288A (en) Pharmaceutical formulations for transdermal administration
HK1015681A1 (en) Rate-controlled transdermal administration of risperidone
AU2393992A (en) Combination therapy using bioflavonoid compounds with anti-cancer drugs
AU4968585A (en) Physiological means of enhancing transdermal delivery of drugs
AU3041789A (en) Pharmaceutical formulations with controlled drug release
AU1450788A (en) Thiophene-2-carbox-amide derivatives and their pharmaceutical use
AU1320195A (en) Use of pyridone derivatives as anesthetic drugs